Effects of Exercise on sRAGE Levels and Cardiometabolic Risk Factors

This study has been completed.
Information provided by (Responsible Party):
K. M. Choi, Korea University
ClinicalTrials.gov Identifier:
First received: February 20, 2012
Last updated: March 1, 2012
Last verified: February 2012

February 20, 2012
March 1, 2012
January 2010
December 2011   (final data collection date for primary outcome measure)
change from baseline in soluble receptor for advanced glycation endproducts (sRAGE) after 12 weeks of aerobic exercise [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01542775 on ClinicalTrials.gov Archive Site
  • anthropometric parameters [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
    body weight, waist circumference, body fat percentage, visceral fat area
  • biochemical parameters [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
    HbA1c, apolipoprotein B, free fatty acid
  • energy expenditure [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
    activity energy expenditure, total energy expenditure
Same as current
Not Provided
Not Provided
Effects of Exercise on sRAGE Levels and Cardiometabolic Risk Factors
Not Provided

The purpose of this study is to examine the effects of exercise on diverse cardiometabolic risk factors and indicators of atherosclerosis in patients with type 2 diabetes mellitus (T2DM).

Not Provided
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Type 2 Diabetes
  • Behavioral: Aerobic Exercise Group
    12 weeks Aerobic exercise
  • Behavioral: Control Group
    maintaining usual activities
  • Placebo Comparator: Control
    Intervention: Behavioral: Control Group
  • Active Comparator: Exercise
    Intervention: Behavioral: Aerobic Exercise Group
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Not Provided
December 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • type 2 diabetes
  • stable body weight
  • sedentary lifestyle

Exclusion Criteria:

  • smoked cigarettes
  • cardiovascular disease
  • chronic kidney
  • chronic liver disease
  • pregnant or breastfeeding
  • any other major illness
18 Years to 85 Years
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
Not Provided
K. M. Choi, Korea University
Korea University
Not Provided
Not Provided
Korea University
February 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP